11/17
08:00 am
grce
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
Low
Report
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
11/13
08:38 am
grce
Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update [Yahoo! Finance]
Low
Report
Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update [Yahoo! Finance]
11/13
08:00 am
grce
Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update
Low
Report
Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update
11/11
09:27 am
grce
Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting [Yahoo! Finance]
Low
Report
Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting [Yahoo! Finance]
11/11
08:30 am
grce
Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting
Low
Report
Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting
11/1
10:32 am
grce
This Grace Therapeutics Insider Increased Their Holding By 12% Last Year [Yahoo! Finance]
Low
Report
This Grace Therapeutics Insider Increased Their Holding By 12% Last Year [Yahoo! Finance]
10/23
08:00 am
grce
Grace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA Review
Medium
Report
Grace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA Review
9/23
10:15 am
grce
We Think Grace Therapeutics (NASDAQ:GRCE) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Low
Report
We Think Grace Therapeutics (NASDAQ:GRCE) Needs To Drive Business Growth Carefully [Yahoo! Finance]
9/22
08:43 am
grce
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting [Yahoo! Finance]
Low
Report
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting [Yahoo! Finance]
9/22
08:00 am
grce
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
Low
Report
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
9/18
08:30 am
grce
Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104
Low
Report
Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104
9/13
01:06 am
grce
Grace Therapeutics (NASDAQ:GRCE) was upgraded by analysts at
Wall Street
Medium
Report
Grace Therapeutics (NASDAQ:GRCE) was upgraded by analysts at
Wall Street